Patent ID: 9539228
Date: 2017-01-10
CPC Classifications: A23L,A23V,A61K,A61P

Claim:
1. A composition suitable for prophylactic and/or therapeutic treatment for herpes infections and/or inflammations of the oral cavity and the throat, characterized in that the composition comprises, based on a daily dose of the composition, as active ingredients the substances below: L-lysine in the range from ≧750 mg to ≦9 g, zinc in the range from ≧9 mg to ≦90 mg, selenium, vitamin B2, vitamin B6, vitamin B12, vitamin C, vitamin D3, folic acid and bioflavonoids and is present in an administration form selected from the group comprising chewable tablets, chewable coated pills, lozenges, pastilles, orally disintegrating tablets, gels, and/or chewing gums, which are chewed, sucked or allowed to disintegrate in the mouth, with the active ingredients being released in the oral cavity to provide an effect directly in the region of the mouth, wherein the composition comprises an effective amount of the active ingredients to treat herpes infections and/or inflammation of the oral cavity and throat.